Austrian Court Hands Ranbaxy Lipitor Win
The five-judge panel of the Supreme Patent and Trademark Board of Austria unanimously affirmed an earlier ruling delivered in March 2005, Ranbaxy revealed on Tuesday.
The decision marks a key departure from the recent verdicts handed down in the Lipitor saga in various...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login